These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 36479110)
1. Comparison of dynamic changes in the peripheral CD8 Wei H; Li Y; Guo Z; Ma X; Li Y; Wei X; Han D; Zhang T; Chen X; Yan C; Zhou J; Pang Q; Wang P; Zhang W Front Immunol; 2022; 13():1060695. PubMed ID: 36479110 [TBL] [Abstract][Full Text] [Related]
2. Radiotherapy plus camrelizumab affects peripheral CD8 T-cell differentiation subsets expressing PD-1, TIGIT, and CTLA-4 in esophageal squamous cell carcinoma. Guo Z; Zhang K; Wei X; Li Y; Ma X; Li Y; Han D; Du Q; Zhang T; Chen X; Wei H; Yan C; Zhang W; Pang Q; Wang P J Leukoc Biol; 2023 Jan; 113(1):11-17. PubMed ID: 36822161 [TBL] [Abstract][Full Text] [Related]
3. Safety and Feasibility of Radiotherapy Plus Camrelizumab for Locally Advanced Esophageal Squamous Cell Carcinoma. Zhang W; Yan C; Gao X; Li X; Cao F; Zhao G; Zhao J; Er P; Zhang T; Chen X; Wang Y; Jiang Y; Wang Q; Zhang B; Qian D; Wang J; Zhou D; Ren X; Yu Z; Zhao L; Yuan Z; Wang P; Pang Q Oncologist; 2021 Jul; 26(7):e1110-e1124. PubMed ID: 33893689 [TBL] [Abstract][Full Text] [Related]
4. Spatial distribution of tumor-infiltrating T cells indicated immune response status under chemoradiotherapy plus PD-1 blockade in esophageal cancer. Yan C; Huang H; Zheng Z; Ma X; Zhao G; Zhang T; Chen X; Cao F; Wei H; Dong J; Tang P; Jiang H; Wang M; Wang P; Pang Q; Zhang W Front Immunol; 2023; 14():1138054. PubMed ID: 37275884 [TBL] [Abstract][Full Text] [Related]
5. Time-spatial analysis of T cell receptor repertoire in esophageal squamous cell carcinoma patients treated with combined radiotherapy and PD-1 blockade. Yan C; Ma X; Guo Z; Wei X; Han D; Zhang T; Chen X; Cao F; Dong J; Zhao G; Gao X; Wang T; Jiang Y; Wang P; Pang Q; Zhang W Oncoimmunology; 2022; 11(1):2025668. PubMed ID: 35036077 [TBL] [Abstract][Full Text] [Related]
6. PD-1 expression on peripheral CD8+ TEM/TEMRA subsets closely correlated with HCV viral load in chronic hepatitis C patients. Shen T; Zheng J; Xu C; Liu J; Zhang W; Lu F; Zhuang H Virol J; 2010 Nov; 7():310. PubMed ID: 21070674 [TBL] [Abstract][Full Text] [Related]
7. RATIONALE 311: tislelizumab plus concurrent chemoradiotherapy for localized esophageal squamous cell carcinoma. Yu R; Wang W; Li T; Li J; Zhao K; Wang W; Liang L; Wu H; Ai T; Huang W; Li L; Yu W; Wei C; Wang Y; Shen W; Xiao Z Future Oncol; 2021 Nov; 17(31):4081-4089. PubMed ID: 34269067 [TBL] [Abstract][Full Text] [Related]
8. Addition of camrelizumab to docetaxel, cisplatin, and radiation therapy in patients with locally advanced esophageal squamous cell carcinoma: a phase 1b study. Zhang W; Yan C; Zhang T; Chen X; Dong J; Zhao J; Han D; Wang J; Zhao G; Cao F; Zhou D; Jiang H; Tang P; Zhao L; Yuan Z; Wang Q; Wang P; Pang Q Oncoimmunology; 2021; 10(1):1971418. PubMed ID: 34616588 [TBL] [Abstract][Full Text] [Related]
9. Tracking Peripheral Memory Kang P; Yu H; Li Y; Wen X; Ye H; Luo Y; Yang Y; Yuan Q; Lin S J Oncol; 2023; 2023():3221510. PubMed ID: 39282224 [TBL] [Abstract][Full Text] [Related]
10. Paired whole exome and transcriptome analyses for the Immunogenomic changes during concurrent chemoradiotherapy in esophageal squamous cell carcinoma. Park S; Joung JG; Min YW; Nam JY; Ryu D; Oh D; Park WY; Lee SH; Choi Y; Ahn JS; Ahn MJ; Park K; Sun JM J Immunother Cancer; 2019 May; 7(1):128. PubMed ID: 31097034 [TBL] [Abstract][Full Text] [Related]
11. Characterization of CD31 expression in CD4+ and CD8+T cell subpopulations in chronic untreated HIV infection. Briceño O; Peralta-Prado A; Garrido-Rodríguez D; Romero-Mora K; Chávez-Torres M; de la Barrera CA; Reyes-Terán G; Ávila-Ríos S Immunol Lett; 2021 Jul; 235():22-31. PubMed ID: 33852965 [TBL] [Abstract][Full Text] [Related]
12. Comprehensive analysis of the immune pattern of T cell subsets in chronic myeloid leukemia before and after TKI treatment. Yao D; Lai J; Lu Y; Zhong J; Zha X; Huang X; Liu L; Zeng X; Chen S; Weng J; Du X; Li Y; Xu L Front Immunol; 2023; 14():1078118. PubMed ID: 36742315 [TBL] [Abstract][Full Text] [Related]
13. [T-lymphocyte immune in HIV-infected people and AIDS patients in China]. Li T; Qiu Z; Wang A; Sheng R Zhonghua Yi Xue Za Zhi; 2002 Oct; 82(20):1391-5. PubMed ID: 12509921 [TBL] [Abstract][Full Text] [Related]
14. Change in PD-L1 and CD8 Expression after Chemoradiotherapy for Esophageal Squamous Cell Carcinoma. Chen WC; Wu CC; Chen YH; Lee JY; Wang YK; Wu NS; Wu MT; Wu IC Biomedicines; 2022 Aug; 10(8):. PubMed ID: 36009434 [TBL] [Abstract][Full Text] [Related]
15. Alteration in tumoural PD-L1 expression and stromal CD8-positive tumour-infiltrating lymphocytes after concurrent chemo-radiotherapy for non-small cell lung cancer. Yoneda K; Kuwata T; Kanayama M; Mori M; Kawanami T; Yatera K; Ohguri T; Hisaoka M; Nakayama T; Tanaka F Br J Cancer; 2019 Sep; 121(6):490-496. PubMed ID: 31388183 [TBL] [Abstract][Full Text] [Related]
16. Three-arm phase II trial comparing camrelizumab plus chemotherapy versus camrelizumab plus chemoradiation versus chemoradiation as preoperative treatment for locally advanced esophageal squamous cell carcinoma (NICE-2 Study). Yang Y; Zhu L; Cheng Y; Liu Z; Cai X; Shao J; Zhang M; Liu J; Sun Y; Li Y; Yi J; Yu B; Jiang H; Chen H; Yang H; Tan L; Li Z BMC Cancer; 2022 May; 22(1):506. PubMed ID: 35524205 [TBL] [Abstract][Full Text] [Related]
17. Dual TGF-β and PD-1 blockade synergistically enhances MAGE-A3-specific CD8 Chen X; Wang L; Li P; Song M; Qin G; Gao Q; Zhang Z; Yue D; Wang D; Nan S; Qi Y; Li F; Yang L; Huang L; Zhang M; Zhang B; Gao Y; Zhang Y Int J Cancer; 2018 Nov; 143(10):2561-2574. PubMed ID: 29981155 [TBL] [Abstract][Full Text] [Related]
18. Comparison of concurrent chemoradiotherapy with radiotherapy alone for locally advanced esophageal squamous cell cancer in elderly patients: A randomized, multicenter, phase II clinical trial. Liu Y; Zheng Z; Li M; Zhang Y; Zhao F; Gong H; Lin H; Huang W; Chen X; Xu Z; Li X; Liu W; Cui Y; Zheng A; Li B Int J Cancer; 2022 Aug; 151(4):607-615. PubMed ID: 35419831 [TBL] [Abstract][Full Text] [Related]
19. Proliferation and differentiation potential of human CD8+ memory T-cell subsets in response to antigen or homeostatic cytokines. Geginat J; Lanzavecchia A; Sallusto F Blood; 2003 Jun; 101(11):4260-6. PubMed ID: 12576317 [TBL] [Abstract][Full Text] [Related]